Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-22 · accession 0001711462-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-23 | 2025-12-22 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $18.50 | +1,500 | 28.5K | +6% | +$27.8K |
| D | 2025-12-23 | 2025-12-22 | ANAB | Lizzul Paul F. | Chief Medical Off | S - Sale+OE | $50.00 | -1,500 | 27.0K | -5% | -$75.0K |
| D | 2025-12-23 | 2025-12-22 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $0.00 | -1,500 | 83.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | M | A | 1,500 | $18.50 | 28,467 | D | — | — | (F1) Includes the acquisition of 1,324 shares acquired under the Company's ESPP. |
| 2 | Common | Common Stock | 2025-12-22 | S | D | 1,500 | $50.00 | 26,967 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-12-22 | M | D | 1,500 | $0.00 | 83,500 | D | $18.50 · — to 2030-07-29 | 1,500 Common Stock | (F4) In addition to the remaining options to purchase 83,500 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 394,810 shares of common stock, which options vest according to their terms. (F3) The stock option is fully vested. |